Trials / Unknown
UnknownNCT01321489
A Study to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet in the Treatment of Erectile Dysfunction of Different Etiologies
A Clinical Phase III, Comparative, Open, Multicenter, Prospectively, to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet, Compared to Viagra ® 50mg Tablet Coated, in the Treatment of Erectile Dysfunction of Different Etiologies
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 78 (estimated)
- Sponsor
- Laboratório Teuto Brasileiro S/A · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the tolerability and safety of Sildenafil Citrate 20mg Sublingual tablet, as well as a possible superiority expressed by the faster onset of action compared to Viagra ® 50mg tablet Coated in erectile dysfunction.
Detailed description
Phase III clinical trial, comparative, open, multicenter, prospectively, with random inflow of 78 patients evaluable male patients with erectile dysfunction with IIEF-5 score in between 13 and 24, corresponding to mild or mild to moderate to evaluate the efficacy and safety as well as a possible superiority expressed by the faster onset of action onset of action of study medication.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sildenafil Citrate 20mg Tablet Sublingual | Administer one tablet of Sildenafil Citrate 20 mg sublingually 10 minutes before intercourse. It is recommended that the administration of just one tablet a day. The patient will receive six tablets of the medication. |
| DRUG | Viagra ® 50mg tablet Coated | Administer one tablet of Viagra ® 50mg tablet Coated orally 1 hour before intercourse. It is recommended that the administration of just one tablet a day. The patient will receive six tablets of the medication. |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2011-03-23
- Last updated
- 2011-03-23
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01321489. Inclusion in this directory is not an endorsement.